Medikaloka Hermina Tbk PT
IDX:HEAL
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1 070
1 595
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Medikaloka Hermina Tbk PT
Medikaloka Hermina Tbk PT
Cost of Revenue
Medikaloka Hermina Tbk PT
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Medikaloka Hermina Tbk PT
IDX:HEAL
|
Cost of Revenue
-Rp4.2T
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
|
|
Siloam International Hospitals Tbk PT
IDX:SILO
|
Cost of Revenue
-Rp7.2T
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-13%
|
|
|
Metro Healthcare Indonesia Tbk PT
IDX:CARE
|
Cost of Revenue
-Rp153B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
N/A
|
|
|
S
|
Sejahteraraya Anugrahjaya Tbk PT
IDX:SRAJ
|
Cost of Revenue
-Rp2T
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
-24%
|
|
|
Mitra Keluarga Karyasehat Tbk PT
IDX:MIKA
|
Cost of Revenue
-Rp2.2T
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-8%
|
|
|
F
|
Famon Awal Bros Sedaya Tbk PT
IDX:PRAY
|
Cost of Revenue
-Rp1.3T
|
CAGR 3-Years
-19%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Medikaloka Hermina Tbk PT
Glance View
PT Medikaloka Hermina engages in healthcare services. The company is headquartered in Jakarta Timur, Dki Jakarta and currently employs 15,086 full-time employees. The company went IPO on 2018-05-16. The firm is focused on providing services for BPJS patients to support government program in Indonesia. The Company’s services include hospitals, specialties and featured services. The Company’s hospitals include Hermina Arcamanik, Hermina Balikpapan, Hermina Banyumanik, Hermina Bekasi, Hermina Bitung, Hermina Bogor, Hermina Ciledug, Hermina Cilegon and Hermina Ciputat. In specialties service, the Company provides anatomical pathology, andrology, anesthesiology, cardiology, clinical microbiology, clinical pathology, dentistry, dermatology and venereology, dietetics, emergency medicine, forensic and medicolegal, internal medicine, medical acupuncture, neurology and surgery. The Company’s subsidiaries include PT Medikaloka Internusa (M Internusa), PT Medikaloka Sejahtera (M Sejahtera), PT Medikaloka Husada (M Husada), PT Medikaloka Daan Mogot and PT Medikaloka Pasteur (M Pasteur).
See Also
What is Medikaloka Hermina Tbk PT's Cost of Revenue?
Cost of Revenue
-4.2T
IDR
Based on the financial report for Sep 30, 2024, Medikaloka Hermina Tbk PT's Cost of Revenue amounts to -4.2T IDR.
What is Medikaloka Hermina Tbk PT's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-18%
Over the last year, the Cost of Revenue growth was -17%. The average annual Cost of Revenue growth rates for Medikaloka Hermina Tbk PT have been -13% over the past three years , -18% over the past five years .
You don't have any saved screeners yet
